ישראל - עברית - Ministry of Health

rafa laboratories ltd - morphine sulfate - תמיסה להזרקה - morphine sulfate 20 mg/ml - morphine - morphine - morphine injection 20 mg/ml is a systemic opioid analgesic indicated only for iv, epidural and intrathecal infusion in the treatment of intractable chronic pain. it was developed for use in continuous microinfusion devices and the dosage requirements of the individual patient. morphine injetion 20 mg/ml is primarily intended for patients who are opioid -tolerant. morphine sulfate administered epidurally or intrathecally provides pain relief for extended periods without attendant loss of motor, sensory or sympathetic function

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 100 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 50 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less. management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrai

ישראל - עברית - Ministry of Health

abbvie biopharmaceuticals ltd, israel - botulinum toxin type a - אבקה להכנת תמיסה לזריקה - botulinum toxin type a 200 u/vial - botulinum toxin - botulinum toxin - botox is indicated for the symptomatic relief of blepharospasm or vii nerve disorders in patients over 12 years hemifacial spasm and associated focal dystonias as well as the correction of strabismus in patients 12 years of age and above. botox is also indicated for the reduction of the signs and symptoms of spasmodic torticollis ( cervical dystonia) in adults. botox is also indicated for the treatment of dynamic equinus foot deformity due to spasticity in paediatric cerebral palsy patients two years of age or older. focal upper limb spasticity associated with stroke. botox is indicated also for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged 65 years or less.management of primary axillary hyperhidrosis in patients who failed other medical symptomatic treatment.symptom relief in adults fulfilling criteria for chronic migraine (headaches on ?15 days per month of which at least 8 days with migrain

ישראל - עברית - Ministry of Health

rafa laboratories ltd - morphine sulfate - טבליה - morphine sulfate 15 mg - morphine - morphine - for the relief of moderate to severe pain.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - morphine sulfate - טבליה - morphine sulfate 30 mg - morphine - morphine - for the relief of moderate to severe pain.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - morphine sulfate - תמיסה להזרקה - morphine sulfate 1 mg/ml - morphine - morphine - for the relief of pain that does not respond to treatment with non-opioid analgesics. morphine injection is a systemic opioid analgesic administered by the iv , epidural and intrathecal routes. morphine sulphate administered epidurally or intrathecally provides pain relief for extended periods without attendant loss of motor, sensory or sympathetic function

ישראל - עברית - Ministry of Health

rafa laboratories ltd - morphine sulfate - טבליות בשחרור מבוקר - morphine sulfate 100 mg - morphine - morphine - prolonged relief of severe pain.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - morphine sulfate - טבליות בשחרור מבוקר - morphine sulfate 30 mg - morphine - morphine - prolonged relief of severe pain.

ישראל - עברית - Ministry of Health

rafa laboratories ltd - morphine sulfate - טבליות בשחרור מבוקר - morphine sulfate 10 mg - morphine - morphine - prolonged relief of severe pain.